Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcutaneous Screening for Risk of Severe Hyperbilirubinemia in South African Newborns

NCT02613676 is registered in ClinicalTrials.gov with University of Stellenbosch as lead sponsor.

NCT NCT02613676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02613676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcutaneous Screening for Risk of Severe Hyperbilirubinemia in South African Newborns
Lead sponsor
University of Stellenbosch
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2015
Completion date
October 31, 2016
Enrollment
1,858 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperbilirubinemia, neonatal jaundice